Synthesis, biological evaluation and molecular modeling studies of Schiff bases derived from 4-methylsalicylic acid as potential immunosuppressive agents

By Yan Ru   Liu Peng-Gang   Zhang Zhi-Ming   Fang Xian-Ying   Zhang Xue-Wei   Deng Jia-Li   Zhu Hai-Liang  

Medicinal Chemistry Research, Vol. 22, Iss. 12, 2013-12 ,pp. : 5707-5716

Springer Publishing Company

Access to resources Recommend Favorite

Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer

By  

CANCER, Vol. 120, Iss. 4, 2014-02 ,pp. : 603-610

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin–bound paclitaxel in patients with advanced solid tumors

By  

CANCER, Vol. 121, Iss. 11, 2015-06 ,pp. : 1817-1826

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Treatment with Mammalian Target of Rapamycin Inhibitor Does Not Benefit Patients with Autosomal Dominant Polycystic Kidney Disease: A Meta-Analysis

By  

Nephron Clin Pract, Vol. 124, Iss. 1-2, 2013-09 ,pp. : 10-16

Karger

Access to resources Recommend Favorite

Mammalian target of rapamycin (mTOR) inhibitor‐associated non‐infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes

By  

BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. : 376-382

John Wiley & Sons Inc

Access to resources Recommend Favorite